Results Briefing Material for Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2019
Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2019
Notice of Capital and Business Alliance with Cyfuse Biomedical K.K.
Notice of Investment with Wingo Technology Co.,Ltd.
Concerning acquisition of new company shares and ownership of Daiichi Sankyo Propharma Co., Ltd. Takatsuki Plant (subsidiary acquisition)
Click here for Shared Research Inc. research report.